BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

878 related articles for article (PubMed ID: 19426212)

  • 1. CD28 and CTLA-4 coreceptor expression and signal transduction.
    Rudd CE; Taylor A; Schneider H
    Immunol Rev; 2009 May; 229(1):12-26. PubMed ID: 19426212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of costimulation.
    Sharpe AH
    Immunol Rev; 2009 May; 229(1):5-11. PubMed ID: 19426211
    [No Abstract]   [Full Text] [Related]  

  • 3. Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase.
    Gigoux M; Shang J; Pak Y; Xu M; Choe J; Mak TW; Suh WK
    Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20371-6. PubMed ID: 19915142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
    Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
    J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kinase PDK1 integrates T cell antigen receptor and CD28 coreceptor signaling to induce NF-kappaB and activate T cells.
    Park SG; Schulze-Luehrman J; Hayden MS; Hashimoto N; Ogawa W; Kasuga M; Ghosh S
    Nat Immunol; 2009 Feb; 10(2):158-66. PubMed ID: 19122654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting edge: the related molecules CD28 and inducible costimulator deliver both unique and complementary signals required for optimal T cell activation.
    Gonzalo JA; Delaney T; Corcoran J; Goodearl A; Gutierrez-Ramos JC; Coyle AJ
    J Immunol; 2001 Jan; 166(1):1-5. PubMed ID: 11123268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PI3-kinase and MAP-kinase signaling cascades in AILIM/ICOS- and CD28-costimulated T-cells have distinct functions between cell proliferation and IL-10 production.
    Okamoto N; Tezuka K; Kato M; Abe R; Tsuji T
    Biochem Biophys Res Commun; 2003 Oct; 310(3):691-702. PubMed ID: 14550257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice.
    Li J; Semple K; Suh WK; Liu C; Chen F; Blazar BR; Yu XZ
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):962-9. PubMed ID: 21447398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A costimulation-initiated signaling pathway regulates NFATc1 transcription in T lymphocytes.
    Nurieva RI; Chuvpilo S; Wieder ED; Elkon KB; Locksley R; Serfling E; Dong C
    J Immunol; 2007 Jul; 179(2):1096-103. PubMed ID: 17617602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-stimulation in T cell responses.
    Chambers CA; Allison JP
    Curr Opin Immunol; 1997 Jun; 9(3):396-404. PubMed ID: 9203422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain.
    Finney HM; Akbar AN; Lawson AD
    J Immunol; 2004 Jan; 172(1):104-13. PubMed ID: 14688315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in allergen-induced T cell activation between allergic asthma and rhinitis: Role of CD28, ICOS and CTLA-4.
    Botturi K; Lacoeuille Y; Cavaillès A; Vervloet D; Magnan A
    Respir Res; 2011 Feb; 12(1):25. PubMed ID: 21356099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting T cell costimulation in autoimmune disease.
    Stuart RW; Racke MK
    Expert Opin Ther Targets; 2002 Jun; 6(3):275-89. PubMed ID: 12223069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.
    Fife BT; Bluestone JA
    Immunol Rev; 2008 Aug; 224():166-82. PubMed ID: 18759926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4(+) T-cell activation is differentially modulated by bacteria-primed dendritic cells, but is generally down-regulated by n-3 polyunsaturated fatty acids.
    Brix S; Lund P; Kjaer TM; Straarup EM; Hellgren LI; Frøkiaer H
    Immunology; 2010 Mar; 129(3):338-50. PubMed ID: 19909377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS).
    Harada Y; Ohgai D; Watanabe R; Okano K; Koiwai O; Tanabe K; Toma H; Altman A; Abe R
    J Exp Med; 2003 Jan; 197(2):257-62. PubMed ID: 12538664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICOS contributes to T cell expansion in CTLA-4 deficient mice.
    van Berkel ME; Schrijver EH; Hofhuis FM; Sharpe AH; Coyle AJ; Broeren CP; Tesselaar K; Oosterwegel MA
    J Immunol; 2005 Jul; 175(1):182-8. PubMed ID: 15972646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expanding world of co-stimulation: the two-signal model revisited.
    Chambers CA
    Trends Immunol; 2001 Apr; 22(4):217-23. PubMed ID: 11274928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-h2 is a costimulatory ligand for CD28 in human.
    Yao S; Zhu Y; Zhu G; Augustine M; Zheng L; Goode DJ; Broadwater M; Ruff W; Flies S; Xu H; Flies D; Luo L; Wang S; Chen L
    Immunity; 2011 May; 34(5):729-40. PubMed ID: 21530327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement.
    Riley JL; Blair PJ; Musser JT; Abe R; Tezuka K; Tsuji T; June CH
    J Immunol; 2001 Apr; 166(8):4943-8. PubMed ID: 11290772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.